Sirnaomics US Competitors and Similar CompaniesClear all
Sirnaomics US's competitors and similar companies include GlycoMimetics, Aura Biosciences, HUYA Bioscience International and Ascendis Pharma.
 Sirnaomics US Sirnaomics is a biopharmaceutical company developing oncology therapeutics by using RNA interference (RNAi) technology. |  GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. |  Aura Biosciences Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology. |  HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products. |  Ascendis Pharma Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology. | |
Founding Date | Founding Date 2007 | Founding Date 2003 | Founding Date 2009 | Founding Date 2004 | Founding Date 2007 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Germantown, US HQ Cambridge, US | Locations Rockville, US HQ | Locations Cambridge, US HQ | Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more | Locations Hellerup, DK HQ Heidelberg, DE Palo Alto, US |
Employees | Employees 3211% decrease | Employees 5025% increase | Employees 42 | Employees 1113% increase | Employees 1,017 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 31.6 m | Valuation ($) 544.2 m | Valuation ($) N/A | Valuation ($) 7.7 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $10.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €720.1m (FY, 2025) |
Net income | Net income N/A | Net income ($153.9m) (FY, 2025) | Net income ($106.2m) (FY, 2025) | Net income N/A | Net income (€228m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 162m | Total funding raised $ 101.8m | Total funding raised $ 213.9m | Total funding raised $ 12.6m | Total funding raised $ 85.8m |
For sources of this data, please see the company profile
View Company Profiles
GlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
View companyAura Biosciences
HQ
Cambridge, US
Employees
42
Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology.
View companyHUYA Bioscience International
HQ
San Diego, US
Employees
111↑ 3% increase
HUYA Bioscience International is a company specializing in the biopharmaceutical products.
View companyAscendis Pharma
HQ
Hellerup, DK
Employees
1,017
Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology.
View company